Page 2 - Obatala Sciences News Today

-Funding accelerates commercialization of research-enabling solutions to speed up therapies for obesity, diabetes, and cancer across diverse populations -- Obatala Sciences’ solutions provide research scientists in pharmaceutical companies, biotech, academia, and government laboratories with models that more accurat...

Odyssey Therapeutics raised $168 million in Series B financing, the largest round of funding for a biotech startup this week. Companies developing new technologies in genetic diseases, cancer, and drug research are represented also represented in this week’s recap of life science financings.

GNO Inc.’s HBCU Startup Internship Program is an eight-week initiative that offers students at historically Black colleges and universities paid internships with local startups.

/PRNewswire/ -- Obatala Sciences, a biotechnology company that manufactures stem cell and hydrogel products to enable next-generation therapeutics discovery,...

Researchers propose new scoring system for assessing wound healing dynamics Evaluating the efficacy of novel therapies requires the ability to monitor wound progression accurately and reproducibly over time. Researchers have proposed a new scoring system for wound healing in mice based on parameters in each phase of healing, as described in an article in the peer-reviewed journal Stem Cells and Development. The parameters include re-epithelization, epithelial thickness index, keratinization, g...

Development by New Orleans biotech company to enable studies of human fat tissue in vitroCAMBRIDGE, Mass. & NEW ORLEANS--(BUSINESS WIRE)--Harvard University has granted an exclusive license to biotechnology company Obatala Sciences to commercialize innovations that enable the study of human fat tissue in vitro. Harv...

/PRNewswire/ -- Obatala Sciences, a biotechnology company that manufactures stem cell and hydrogel products to enable next-generation therapeutics discovery,...

Development by New Orleans biotech company to enable studies of human fat tissue in vitro ...

Obatala Sciences, Harvard partner on human fat tissue study New Orleans-based biotechnology firm Obatala Sciences has been granted an exclusive license from Harvard University to commercialize innovations that enable the study of human fat tissue in vitro. The licensed Harvard technology, an adipose-on-a-chip, provides a method of obtaining adult-size fat tissue cells for study in vitro and enables the testing of weight loss and cancer-targeting therapeutics without the need for testing in ani...

Dr. Calvin Mackie In an extraordinary experience, 12 New Orleans teens will learn about stem cell research and tissue engineering from biotechnology professionals This type of engagement with professionals who do this work on a daily basis is life changing. It will continue building on the interest and promise these students have already shown in STEM fields” — Dr. Calvin Mackie NEW ORLEANS, LOUISIANA , UNITED STATES, April 30, 2021 /EINPresswire.com/ -- STEM NOLA is proud to partner with O...